MIGUEL JOSE
MARTIN JIMÉNEZ
Profesor emérito
Northwestern University
Evanston, Estados UnidosPublicacions en col·laboració amb investigadors/es de Northwestern University (5)
2021
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2016
-
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy
European Journal of Cancer, Vol. 56, pp. 85-92
2015
-
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer
European Journal of Cancer
-
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy
Breast Cancer Research, Vol. 17, Núm. 1
2013
-
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial
The Lancet Oncology, Vol. 14, Núm. 1, pp. 88-96